Back
Titan Pharmaceuticals 10K Form
Sell
39
TTNP
Titan Pharmaceuticals
Last Price:
$3.64
Seasonality Move:
107.6%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-14 | 10Q | TTNP/Titan Pharmaceuticals Quarterly |
| 2023-08-14 | 10Q | TTNP/Titan Pharmaceuticals Quarterly |
| 2023-05-15 | 10Q | TTNP/Titan Pharmaceuticals Quarterly |
| 2022-11-14 | 10Q | TTNP/Titan Pharmaceuticals Quarterly |
| 2022-08-11 | 10Q | TTNP/Titan Pharmaceuticals Quarterly |
| 2022-05-16 | 10Q | TTNP/Titan Pharmaceuticals Quarterly |
Receive TTNP News And Ratings
See the #1 stock for the next 7 days that we like better than TTNP
TTNP Financial Statistics
Sales & Book Value
| Annual Sales: | $1K |
|---|---|
| Cash Flow: | $-506K |
| Price / Cash Flow: | 0 |
| Annual Sales: | $2.67 |
| Price / Book: | 1.41 |
Profitability
| EPS (TTM): | -5.21000 |
|---|---|
| Net Income (TTM): | $-4.7M |
| Gross Margin: | $60K |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Titan Pharmaceuticals Earnings Forecast
Key Titan Pharmaceuticals Financial Ratios
Titan Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | TTNP |
| CUSIP: | 888314 |
| Website: | titanpharm.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
TTNP Technical Analysis vs Fundamental Analysis
Sell
39
Titan Pharmaceuticals (TTNP)
is a Sell
Is Titan Pharmaceuticals a Buy or a Sell?
-
Titan Pharmaceuticals stock is rated a SellThe current Titan Pharmaceuticals [TTNP] share price is $3.75. The Score for TTNP is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.